BrainAurora Medical Technology Limited

Research BrainAurora Medical Technology Limited (6681.HK) on Bullrun: market cap HKD 818.87M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 818.87M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 220.05M-CNY 314.86M-CNY 205.75M40.7%-0.27CNY 430.36MCNY 565.52MCNY 97.35M
FY2024CNY 122.31M-CNY 198.28M-CNY 163.85M44.2%-0.22CNY 343.88MCNY 388.28M-CNY 463.65M
FY2023CNY 67.20M-CNY 359.08M-CNY 155.00M47.7%-0.4CNY 57.58MCNY 364.08M-CNY 332.14M
FY2022CNY 11.29M-CNY 502.45M-CNY 119.74M29.2%-0.4CNY 58.43MCNY 328.14M-CNY 1.09B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 818.87Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About BrainAurora Medical Technology Limited

BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China. The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychiatric disorders, and child development deficiencies.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is BrainAurora Medical Technology Limited's market cap?

BrainAurora Medical Technology Limited's market capitalization is HKD 818.87M.

What does BrainAurora Medical Technology Limited do?

BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China. The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychiatric disorders, and child development deficiencies.